해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.10. (금)

구분	보고서 (영문)
제약/바이오/ 임상시험 (14건)	Tymlos Outperforms Teriparatide in Real-World Fracture Analysis
	Interim Analysis of APPLAUSE-IgAN Trial Sheds Positive Light on Fabhalta for IgAN
	World Immunization Week 2024: mRNA Vaccines Could Reduce Preventable Illness Across Multiple Disease Areas
	The Privileged Status of Orphan Medicines in Germany
	Key Opinion Leaders on GLP-1 Receptor Agonist Clinical Trial Design
	APAC Leads in Clinical Trials for Asthma During 2019–23
	AstraZeneca’s Fasenra: Approval for Asthma may initiate COPD Approval
	Central Nervous System Remains Most Researched Therapy Area for DCTs
	ESCMID Global 2024: Cutting-Edge Vaccines in Development for a Healthier Tomorrow
	Jemperli Contends with Blockbuster Keytruda in Endometrial Cancer
	FDA Approves Alecensa as Leading-Edge Adjuvant Therapy for ALK-Positive Lung Cancer
	ESCMID Global 2024: Drug Resistance in Fungi – a Growing Issue
	Insmed’s Brensocatib: A Candidate for Bronchiectasis Treatment, Closer to Approval
	ESCMID Global 2024: Advances in Drug Resistance Testing
질환별 (9건)	Friedreich Ataxia: Competitive Landscape
	Post-operative Pain: Competitive Landscape
	The Role of CAR-T Cells in Systemic Lupus Erythematosus
	ESCMID Global 2024: The Infectious Consequences of Climate Change
	ESCMID Global 2024: Highlights on Prophylaxis and Treatment of Infectious Diseases
	HER2-Positive Breast Cancer: Epidemiology Forecast to 2033
	ESCMID Global 2024: Long-Acting Injectables for HIV Prevention
	ESCMID Global 2024: Emerging Bacterial Infections in Neonates and Children
	Osteoporosis: Epidemiology Forecast to 2033
컨퍼런스/ 심포지엄/ 학회/기타 (4건)	ACC 2024: Arrowhead Pharmaceuticals Presents New Phase II Data at the American College of Cardiology 2024
	The Wolbachia Method in the Battle Against Dengue
	ACC: EMPACT-MI Study Fails to Meet Primary Endpoint
	Extended Time Spent Indoors in School Increases the Risk of Shortsightedness

​